• Users Online: 766
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2014  |  Volume : 39  |  Issue : 4  |  Page : 202-208

Prognostic impact of neuropilin-1 expression in children with B-lineage acute lymphoblastic leukemia


1 Clinical Pathology Department, Tanta University, Tanta, Egypt
2 Pediatric Department, Faculty of Medicine, Tanta University, Tanta, Egypt

Correspondence Address:
Nahla A Nosair
Department of Clinical Pathology, Tanta University, Tanta, 31111
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1110-1067.153947

Rights and Permissions

Background Neuropilins are transmembrane glycoproteins that act as receptors for vascular endothelial growth factors and are involved in the process of tumor angiogenesis. Objective The aim of this work was to study the prognostic value of neuropilin-1 (NRP-1) expression in children with B-lineage acute lymphoblastic leukemia (ALL). Patients and methods We analyzed NRP-1 expression level in 50 newly diagnosed children with B-lineage ALL and in 20 healthy controls using flow cytometry. Expression of NRP-1 at diagnosis was correlated with standard clinical and laboratory prognostic features. Results The present study revealed a highly significant difference in NRP-1 expression between ALL patients and controls; the mean percentage expression of NRP-1 on bone marrow (BM) blasts of B-ALL patients was 36.86% overall. The highest levels of NRP-1 expression were noted in pre-B-ALL (74.04%) followed by early pre-B-ALL (23.55%) patients, and the lowest expression levels were in mature B-ALL (12.06%) patients, with significant differences between the three subtypes. The expression of NRP-1 was significantly associated with higher white blood cell count, bone marrow blast percentage, and serum lactate dehydrogenase levels at diagnosis. Also, there was a significant association between higher NRP-1 expression and both Philadelphia-positive and CD10-negative ALL types. We found significantly higher levels of NRP-1 expression on BM blasts at diagnosis in patients who relapsed or died compared with those who achieved and maintained complete remission; patients with higher NRP-1 expression had significantly shorter overall survival and disease-free survival than did patients expressing NRP-1 on less than 20% of their BM blasts. Conclusion Our findings suggest that NRP-1 is significantly expressed in children with B-lineage ALL, especially with the pre-B phenotype, and has a bad prognostic impact on the course of this disease. Recommendations We recommend the incorporation of NRP-1 as a prognostic marker in children with B-lineage ALL to offer a chance for intensive therapeutic intervention in patients designated as having poor prognosis, and for studying its role as a potential target for antileukemic and antiangiogenic therapy. Egyptian J Haematol 39:-0 © 2014 The Egyptian Society of Haematology.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed809    
    Printed18    
    Emailed0    
    PDF Downloaded111    
    Comments [Add]    

Recommend this journal